Literature DB >> 18089357

Effect of Lactobacillus casei DN-114001 application on the activity of fecal enzymes in children after liver transplantation.

J Pawłowska1, E Klewicka, P Czubkowski, I Motyl, I Jankowska, Z Libudzisz, M Teisseyre, D Gliwicz, B Cukrowska.   

Abstract

Immunosuppressive and antibacterial regimens in children after liver transplantation create a gut microflora imbalance that can be indirectly measured by the activity of fecal enzymes. The aim of this study was to specify the influence of diet supplementation with probiotic Lactobacillus casei DN on the activity of beta-glucuronidase, beta-glucosidase, and urease. Twenty-five children after liver transplantation (13 girls, 12 boys) ages 3 to 17 years were enrolled in the study. Two months after bacteria application the levels of all 3 enzymes decreased, reaching statistical significance for beta-glucuronidase and beta-glucosidase. Complete rebound in enzyme activity was observed months after the end of probiotic supplementation. We concluded that Lactobacillus casei DN-114001 consumption decreased fecal enzyme activity, a beneficial effect limited to the period of bacteria intake.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18089357     DOI: 10.1016/j.transproceed.2007.03.101

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  6 in total

1.  Oral probiotics and the female urinary microbiome: a double-blinded randomized placebo-controlled trial.

Authors:  Birte J Wolff; Travis K Price; Cara J Joyce; Alan J Wolfe; Elizabeth R Mueller
Journal:  Int Urol Nephrol       Date:  2019-09-18       Impact factor: 2.370

2.  Impact of Probiotics for Reducing Infections in Veterans (IMPROVE): Study protocol for a double-blind, randomized controlled trial to reduce carriage of Staphylococcus aureus.

Authors:  Shoshannah Eggers; Anna Barker; Susan Valentine; Timothy Hess; Megan Duster; Nasia Safdar
Journal:  Contemp Clin Trials       Date:  2016-11-09       Impact factor: 2.226

3.  Probiotic as a novel treatment strategy against liver disease.

Authors:  Abbas Ali Imani Fooladi; Hamideh Mahmoodzadeh Hosseini; Mohammad Reza Nourani; Soghra Khani; Seyed Moayed Alavian
Journal:  Hepat Mon       Date:  2013-02-25       Impact factor: 0.660

4.  Growth inhibition of hepatocellular carcinoma Huh7 cells by Lactobacillus casei extract.

Authors:  Dae Jong Han; Jong Bin Kim; Seo Young Park; Man Gil Yang; Hyuncheol Kim
Journal:  Yonsei Med J       Date:  2013-09       Impact factor: 2.759

5.  Comparative genome analysis of Lactobacillus casei strains isolated from Actimel and Yakult products reveals marked similarities and points to a common origin.

Authors:  François P Douillard; Ravi Kant; Jarmo Ritari; Lars Paulin; Airi Palva; Willem M de Vos
Journal:  Microb Biotechnol       Date:  2013-07-01       Impact factor: 5.813

Review 6.  The importance of nutrition for pediatric liver transplant patients.

Authors:  Joanna Pawłowska
Journal:  Clin Exp Hepatol       Date:  2016-08-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.